Bio-Techne Corp ROA 2006-2019 | TECH

Current and historical return on assets (ROA) values for Bio-Techne Corp (TECH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Bio-Techne Corp ROA for the three months ending September 30, 2019 was 8.14%.
Bio-Techne Corp ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $0.09B $1.93B 4.94%
2019-06-30 $0.10B $1.88B 5.14%
2019-03-31 $0.12B $1.87B 6.79%
2018-12-31 $0.10B $1.85B 5.60%
2018-09-30 $0.13B $1.87B 7.71%
2018-06-30 $0.13B $1.59B 8.07%
2018-03-31 $0.11B $1.62B 7.22%
2017-12-31 $0.12B $1.56B 7.45%
2017-09-30 $0.07B $1.53B 4.76%
2017-06-30 $0.08B $1.56B 4.96%
2017-03-31 $0.07B $1.53B 5.19%
2016-12-31 $0.08B $1.52B 6.20%
2016-09-30 $0.10B $1.52B 8.24%
2016-06-30 $0.11B $1.13B 9.31%
2016-03-31 $0.11B $1.12B 9.45%
2015-12-31 $0.10B $1.13B 8.94%
2015-09-30 $0.11B $1.13B 9.61%
2015-06-30 $0.11B $1.06B 9.94%
2015-03-31 $0.11B $1.10B 10.53%
2014-12-31 $0.12B $1.12B 12.11%
2014-09-30 $0.11B $1.02B 12.30%
2014-06-30 $0.11B $0.86B 13.56%
2014-03-31 $0.11B $0.83B 14.04%
2013-12-31 $0.11B $0.80B 14.49%
2013-09-30 $0.11B $0.78B 14.86%
2013-06-30 $0.11B $0.78B 15.05%
2013-03-31 $0.11B $0.76B 15.22%
2012-12-31 $0.11B $0.73B 15.49%
2012-09-30 $0.11B $0.71B 16.20%
2012-06-30 $0.11B $0.72B 17.02%
2012-03-31 $0.11B $0.68B 17.85%
2011-12-31 $0.11B $0.62B 18.43%
2011-09-30 $0.11B $0.63B 19.12%
2011-06-30 $0.11B $0.62B 19.50%
2011-03-31 $0.11B $0.58B 20.02%
2010-12-31 $0.11B $0.56B 20.78%
2010-09-30 $0.11B $0.54B 20.93%
2010-06-30 $0.11B $0.52B 21.67%
2010-03-31 $0.11B $0.52B 21.99%
2009-12-31 $0.11B $0.50B 22.07%
2009-09-30 $0.10B $0.49B 22.67%
2009-06-30 $0.11B $0.47B 22.84%
2009-03-31 $0.11B $0.44B 22.85%
2008-12-31 $0.11B $0.43B 22.72%
2008-09-30 $0.11B $0.51B 22.10%
2008-06-30 $0.10B $0.51B 21.18%
2008-03-31 $0.10B $0.49B 20.92%
2007-12-31 $0.09B $0.49B 20.31%
2007-09-30 $0.09B $0.48B 20.22%
2007-06-30 $0.09B $0.46B 20.61%
2007-03-31 $0.08B $0.43B 20.69%
2006-12-31 $0.08B $0.40B 20.80%
2006-09-30 $0.08B $0.39B 21.53%
2006-06-30 $0.07B $0.37B 21.77%
2006-03-31 $0.07B $0.34B 23.08%
2005-12-31 $0.07B $0.31B 23.65%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.396B $0.714B
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.614B 16.54
CSL (CSLLY) Australia $93.536B 0.00
Gilead Sciences (GILD) United States $81.096B 10.05
Vertex Pharmaceuticals (VRTX) United States $60.212B 61.46
Biogen (BIIB) United States $52.886B 9.08
Illumina (ILMN) United States $47.097B 51.68
Regeneron Pharmaceuticals (REGN) United States $42.902B 18.79
Alexion Pharmaceuticals (ALXN) United States $24.902B 12.30
Seattle Genetics (SGEN) United States $18.278B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.348B 40.27
BioMarin Pharmaceutical (BMRN) United States $15.963B 0.00
Genmab (GNMSF) Denmark $14.195B 62.70
Alnylam Pharmaceuticals (ALNY) United States $13.166B 0.00
Galapagos (GLPG) Belgium $11.944B 30.77
Exact Sciences (EXAS) United States $11.645B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.484B 55.12
BeiGene (BGNE) Cayman Islands $10.078B 0.00
Sarepta Therapeutics (SRPT) United States $9.709B 0.00
BioNTech SE (BNTX) Germany $7.817B 0.00
QIAGEN (QGEN) Netherlands $7.661B 24.98
Guardant Health (GH) United States $7.568B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.069B 17.97
ACADIA Pharmaceuticals (ACAD) United States $6.993B 0.00
Amarin (AMRN) Ireland $6.930B 0.00
Moderna (MRNA) United States $6.745B 0.00
Reata Pharmaceuticals (RETA) United States $6.431B 0.00
Exelixis (EXEL) United States $6.197B 17.43
Ascendis Pharma (ASND) Denmark $5.865B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.816B 0.00
Bluebird Bio (BLUE) United States $5.186B 0.00
Repligen (RGEN) United States $5.185B 93.96
China Biologic Products (CBPO) China $4.609B 25.97
MorphoSys AG (MOR) Germany $4.179B 0.00
Blueprint Medicines (BPMC) United States $3.949B 0.00
Mirati Therapeutics (MRTX) United States $3.866B 0.00
Immunomedics (IMMU) United States $3.784B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.694B 0.00
Adaptive Biotechnologies (ADPT) United States $3.682B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
MyoKardia (MYOK) United States $3.517B 0.00
NeoGenomics (NEO) United States $3.382B 179.97
CRISPR Therapeutics AG (CRSP) Switzerland $3.288B 0.00
Alkermes (ALKS) Ireland $3.150B 0.00
UniQure (QURE) Netherlands $3.034B 0.00
Zai Lab (ZLAB) China $3.006B 0.00
Genmab (GMAB) Denmark $2.971B 6.12
Halozyme Therapeutics (HALO) United States $2.965B 0.00
Acceleron Pharma (XLRN) United States $2.884B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.862B 0.00
Emergent Biosolutions (EBS) United States $2.837B 28.18
Amicus Therapeutics (FOLD) United States $2.647B 0.00
Epizyme (EPZM) United States $2.382B 0.00
Arena Pharmaceuticals (ARNA) United States $2.264B 5.27
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Myriad Genetics (MYGN) United States $2.183B 32.25
Insmed (INSM) United States $2.134B 0.00
Denali Therapeutics (DNLI) United States $1.977B 0.00
Fate Therapeutics (FATE) United States $1.850B 0.00
Principia Biopharma (PRNB) United States $1.811B 0.00
REGENXBIO (RGNX) United States $1.752B 0.00
Arvinas (ARVN) United States $1.742B 0.00
Zymeworks (ZYME) Canada $1.732B 0.00
Akcea Therapeutics (AKCA) United States $1.717B 0.00
Editas Medicine (EDIT) United States $1.682B 0.00
Ligand Pharmaceuticals (LGND) United States $1.602B 30.82
Orchard Therapeutics (ORTX) United Kingdom $1.482B 0.00
Intra-Cellular Therapies (ITCI) United States $1.460B 0.00
Innoviva (INVA) United States $1.458B 4.30
Dicerna Pharmaceuticals (DRNA) United States $1.395B 0.00
Coherus BioSciences (CHRS) United States $1.389B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.352B 0.00
Alector (ALEC) United States $1.303B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.195B 0.00
DBV Technologies S.A (DBVT) France $1.166B 0.00
Zealand Pharma (ZEAL) Denmark $1.148B 0.00
Codexis (CDXS) United States $1.083B 0.00
Revance Therapeutics (RVNC) United States $1.033B 0.00
PHARMA MAR SA (PHMMF) Spain $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.019B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.897B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.879B 0.00
Mesoblast (MESO) Australia $0.832B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.807B 6.78
Cellectis S.A (CLLS) France $0.785B 0.00
Twist Bioscience (TWST) United States $0.782B 0.00
GENFIT S.A (GNFT) France $0.775B 0.00
Heska (HSKA) United States $0.767B 195.98
Vericel (VCEL) United States $0.760B 283.33
Cytokineticsorporated (CYTK) United States $0.749B 0.00
Sorrento Therapeutics (SRNE) United States $0.732B 0.00
Adverum Biotechnologies (ADVM) United States $0.732B 0.00
Intellia Therapeutics (NTLA) United States $0.725B 0.00
ANI Pharmaceuticals (ANIP) United States $0.720B 12.28
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Retrophin (RTRX) United States $0.703B 0.00
Anika Therapeutics (ANIK) United States $0.682B 22.12
UROGEN PHARMA (URGN) United States $0.679B 0.00
Cara Therapeutics (CARA) United States $0.672B 0.00
AC Immune SA (ACIU) Switzerland $0.668B 15.45
Prothena (PRTA) Ireland $0.608B 0.00
Precision BioSciences (DTIL) United States $0.591B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.588B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.522B 0.00
NantKwest (NK) United States $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Agenus (AGEN) United States $0.511B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.511B 0.00
Dynavax Technologies (DVAX) United States $0.481B 0.00
Bellus Health (BLU) Canada $0.480B 0.00
Arcus Biosciences (RCUS) United States $0.475B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.470B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.453B 3.13
Xenon Pharmaceuticals (XENE) Canada $0.438B 0.00
Pfenex (PFNX) United States $0.433B 0.00
AnaptysBio (ANAB) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.420B 0.00
Kindred Biosciences (KIN) United States $0.406B 0.00
Gritstone Oncology (GRTS) United States $0.405B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.49
Avid Bioservices (CDMO) United States $0.368B 0.00
Merus (MRUS) Netherlands $0.365B 0.00
Cue Biopharma (CUE) United States $0.365B 0.00
CytomX Therapeutics (CTMX) United States $0.355B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Stemline Therapeutics (STML) United States $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
Inovio Pharmaceuticals (INO) United States $0.335B 0.00
Cel-Sci (CVM) United States $0.328B 0.00
Puma Biotechnology (PBYI) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
VBI Vaccines (VBIV) United States $0.324B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
MannKind (MNKD) United States $0.314B 0.00
Geron (GERN) United States $0.298B 0.00
Compugen (CGEN) Israel $0.297B 0.00
Mersana Therapeutics (MRSN) United States $0.295B 0.00
IVERIC Bio (ISEE) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.273B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Prometic Life Sciences (LMNL) Canada $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.261B 0.00
ChromaDex (CDXC) United States $0.261B 0.00
Kamada (KMDA) Israel $0.260B 7.60
OSMOTICA PHARM (OSMT) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Theratechnologies (THTX) Canada $0.235B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
Seres Therapeutics (MCRB) United States $0.229B 0.00
Exicure (XCUR) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.219B 0.00
Affimed (AFMD) Germany $0.217B 0.00
Cerecor (CERC) United States $0.216B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.215B 0.00
XOMA (XOMA) United States $0.210B 0.00
Athersys (ATHX) United States $0.204B 0.00
ARAVIVE, INC (ARAV) United States $0.198B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.195B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.191B 0.00
Alcobra (ARCT) United States $0.184B 0.00
Five Prime Therapeutics (FPRX) United States $0.181B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.176B 0.00
Spero Therapeutics (SPRO) United States $0.175B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Fortress Biotech (FBIO) United States $0.168B 0.00
TELA Bio (TELA) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.164B 4.46
Dyadic (DYAI) United States $0.153B 0.00
Verastem (VSTM) United States $0.152B 0.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Selecta Biosciences (SELB) United States $0.142B 0.00
Novavax (NVAX) United States $0.141B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.128B 0.00
Strongbridge Biopharma (SBBP) United States $0.125B 3.33
Arsanis (XFOR) United States $0.124B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
Aptinyx (APTX) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
BioTime (LCTX) United States $0.110B 5.65
OvaScience (MLND) United States $0.108B 0.00
Clearside Biomedical (CLSD) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.104B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.103B 0.00
Acorda Therapeutics (ACOR) United States $0.102B 0.00
Synlogic (SYBX) United States $0.102B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
Emmaus Life Sciences (EMMA) United States $0.091B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.080B 0.00
Orgenesis (ORGS) United States $0.080B 5.18
Catabasis Pharmaceuticals (CATB) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Checkpoint Therapeutics (CKPT) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.052B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.050B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Soligenix (SNGX) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Oncobiologics (OTLK) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
IBio (IBIO) United States $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00